Start the conversation
It's not often that you get a chance to get in on the "ground floor" of an entire new business.
But that's just what you have here.
In the past, you've heard me say that we are living in the "Golden Age of Materials Science." You see, without Miracle Materials – and the science that backs them – we simply wouldn't have some of the unique high-tech products we take for granted: smartphones, electric cars, and new drug therapies just to name a few.
Today, I want to talk with you about three of the Miracle Materials sectors that I'm targeting … and to tell you about one of the best super-low-priced stocks to buy – with 300% profit potential.
So let's get down to it…
Miracle Material No. 1: Synthetic DNA
I was having dinner with the chief executive officer of a biotech firm not long ago when the conversation wound around to Miracle Materials. To underscore their importance, Miracle Materials scientists are now participants very early in the product-discovery phase of the global-tech ecosystem. Advanced technologies, you see, now require breakthroughs in a wide range of materials – from polymers to metals to medical molecules.
Nowhere is this need more obvious than with the development of synthetic vaccines.
Since synthetic vaccines stem from fragments of man-made DNA, the idea is to "program" them to fight the flu or other diseases.
I see this approach as a "Disruptive Technology" that will turn the $30 billion vaccine market inside out. Besides the flu, firms in this space are working on synthetic vaccines for leukemia, HIV, malaria, hepatitis, and cancer.
Currently, no firm has a synthetic product on the market for human use. But trust me, those products are coming. Several are in clinical trials right now – just awaiting U.S. Food and Drug Administration (FDA) approval.
This field of materials science is extremely important for a couple of reasons.
About the Author
Michael A. Robinson is a 35-year Silicon Valley veteran and one of the top technology financial analysts working today. He regularly delivers winning trade recommendations to the Members of his monthly tech investing newsletter, Nova-X Report, and small-cap tech service, Radical Technology Profits. In the past two years alone, his subscribers have seen over 100 double- and triple-digit gains from his recommendations.
As a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs and high-profile industry insiders. In fact, he was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon. And he was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
In addition to being a regular guest and panelist on CNBC and Fox Business Network, Michael is also a Pulitzer Prize-nominated writer and reporter. His first book, "Overdrawn: The Bailout of American Savings" warned people about the coming financial collapse - years before "bailout" became a household word.
You can follow Michael's tech insight and product updates for free with his Strategic Tech Investor newsletter.